Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vital Farms (VITL) Asset Writedowns and Impairment (2019 - 2023)

Vital Farms' Asset Writedowns and Impairment history spans 5 years, with the latest figure at $120000.0 for Q1 2023.

  • For Q1 2023, Asset Writedowns and Impairment rose 513.79% year-over-year to $120000.0; the TTM value through Mar 2023 reached $187000.0, up 233.57%, while the annual FY2025 figure was $4.7 million, 1472.24% up from the prior year.
  • Asset Writedowns and Impairment for Q1 2023 was $120000.0 at Vital Farms, up from $58000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $326000.0 in Q4 2019 and bottomed at -$139000.0 in Q4 2020.
  • The 5-year median for Asset Writedowns and Impairment is $14000.0 (2020), against an average of $36750.0.
  • The largest annual shift saw Asset Writedowns and Impairment crashed 142.64% in 2020 before it surged 513.79% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $326000.0 in 2019, then plummeted by 142.64% to -$139000.0 in 2020, then skyrocketed by 127.34% to $38000.0 in 2021, then skyrocketed by 52.63% to $58000.0 in 2022, then surged by 106.9% to $120000.0 in 2023.
  • Per Business Quant, the three most recent readings for VITL's Asset Writedowns and Impairment are $120000.0 (Q1 2023), $58000.0 (Q4 2022), and -$29000.0 (Q1 2022).